Mutations in <i>LZTR1</i> add to the complex heterogeneity of schwannomatosis
Miriam J. Smith(Manchester Academic Health Science Centre), D. Gareth Evans(Manchester Academic Health Science Centre), Dorothy Halliday(Oxford University Hospitals NHS Trust), Simon G. Williams(Manchester Metropolitan University), Daniel du Plessis(NIHR Manchester Biomedical Research Centre), Amir Samii(International Neuroscience Institute), Jill Urquhart(University of Manchester), Samantha J. Mills(University of Manchester), James O’Sullivan(NIHR Manchester Biomedical Research Centre), Sanjeev S. Bhaskar(Manchester Metropolitan University), S. Barbarot(Hotel Dieu Hospital), Wilfrid Richer(Université Paris Sciences et Lettres), B. Isidor(Génétique Médicale & Génomique Fonctionelle), Beverly Anderson(NIHR Manchester Biomedical Research Centre), William G. Newman(Manchester Metropolitan University), Christian Beetz(Jena University Hospital), Sarah B. Daly(Centre de Recherche Jean Pierre Aubert), Franck Bourdeaut(Institut Curie), Alan Fryer(University of Liverpool), Cecilie F. Rustad(University of Oslo)
Cited by 124
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833